Accumold
Accumold has announced that it will be showcasing a variety of innovative medical parts and components at the MEDevice (formerly BIOMEDevice) show in Boston on September 25-26, 2024, booth 815. Accumold says the products on display will reflect the company’s experience and deep understanding of design for micro manufacturing (DfMM).
Accumold's offerings include design and material support, micro tool fabrication, proprietary micro moulding services, advanced metrology, assembly, and automation. This integration streamlines the medical product development process, optimising timeliness, innovation, cost, and accuracy says the company.
Brett Saddoris, Accumold’s Technical Marketing Manager says, “We are excited to be at MEDevice Boston, and we are proud to have collaborated with numerous leading medical device manufacturers globally, working strategically with each to ensure the most efficient product development process. The key to success lies in medical device OEMs viewing their micro moulder not just as a job shop but as a partner from the earliest stages of the design-to-market process to avoid costly errors.
"Manufacturing micro medical plastic products necessitates a genuine partnership between OEMs and micro moulding specialists, distinct from traditional OEM/supplier relationships. In micro manufacturing, the most critical issues often arise during the design and prototyping stages, including material selection and packaging considerations. A true partnership ensures faster time-to-market with more efficient and cost-effective products.”
Micro moulding for medical device OEMs requires years of expertise and the right business culture, personnel, and equipment to ensure project success says Accumold. Micro moulders handle low, medium, and high volume runs with various materials, requiring different validation levels. They must also manage the handling, storage, and processing of costly, sensitive materials used in critical implantable applications.
Saddoris added: “Medical device OEMs are under pressure to maintain profitability despite decreasing prices, which necessitates the development of innovative products that meet increasingly stringent end-user demands. There will be a growing need for versatile devices that leverage the potential of 'smart' diagnostics and treatment through the proliferation of 'big data,' as well as cost-effective alternatives to traditionally expensive diagnostic and therapeutic devices. Micro moulding is the preferred solution for many medical device OEMs to meet these rigorous manufacturing requirements.”
Accumold’s micro moulding process enables the production of miniature, complex, and feature-rich components efficiently, cost-effectively, and in large volumes. The expert use of micro moulding technologies provides medical device OEMs with a competitive edge, driving both product innovation and profitability.
High-quality parts with precise dimensional accuracy are crucial for sensitive medical applications, including specialised devices for cancer treatment and diagnosis, small moulded catheter tips, micro-needles, small surgical instruments, dental implants, infection control devices, and staples, among others.
